Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 2020
Historique:
received: 04 10 2018
accepted: 30 04 2019
pubmed: 3 5 2019
medline: 28 4 2021
entrez: 4 5 2019
Statut: ppublish

Résumé

The functional diversity of cells that compose myeloid malignancies, i.e., the respective roles of genetic and epigenetic heterogeneity in this diversity, remains poorly understood. This question is addressed in chronic myelomonocytic leukemia, a myeloid neoplasm in which clinical diversity contrasts with limited genetic heterogeneity. To generate induced pluripotent stem cell clones, we reprogrammed CD34

Identifiants

pubmed: 31048357
pii: haematol.2018.208488
doi: 10.3324/haematol.2018.208488
pmc: PMC6939510
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-123

Subventions

Organisme : NCI NIH HHS
ID : P30 CA240139
Pays : United States

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Cell Stem Cell. 2017 Mar 2;20(3):315-328.e7
pubmed: 28215825
Cell. 2017 Feb 9;168(4):613-628
pubmed: 28187284
Blood. 2013 Sep 19;122(12):2047-51
pubmed: 23940280
Exp Hematol. 2019 Mar;71:77-84
pubmed: 30481543
Cancer Discov. 2014 Mar;4(3):348-61
pubmed: 24356097
Nucleic Acids Res. 2014 Jul;42(13):e105
pubmed: 24878920
Nature. 2013 Apr 11;496(7444):229-32
pubmed: 23552896
J Clin Invest. 2015 May;125(5):1857-72
pubmed: 25822018
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1964-1969
pubmed: 28167771
Blood Adv. 2017 Jun 13;1(14):972-979
pubmed: 29296739
Bioinformatics. 2014 Sep 1;30(17):2414-22
pubmed: 24836530
Blood. 2013 Mar 21;121(12):2186-98
pubmed: 23319568
Nat Rev Mol Cell Biol. 2013 Jun;14(6):357-68
pubmed: 23673969
Stem Cell Reports. 2018 May 8;10(5):1610-1624
pubmed: 29681544
Sci Rep. 2018 Oct 26;8(1):15855
pubmed: 30367142
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
PLoS Genet. 2012;8(6):e1002781
pubmed: 22737091
Cell Stem Cell. 2017 Mar 2;20(3):329-344.e7
pubmed: 28089908
Nat Med. 2016 Jul;22(7):792-9
pubmed: 27322744
Nat Commun. 2016 Feb 24;7:10767
pubmed: 26908133
Blood. 2017 Jul 27;130(4):397-407
pubmed: 28576879
Nat Rev Cancer. 2017 Jun 23;17(7):425-440
pubmed: 28642604
Nat Cell Biol. 2017 Apr;19(4):271-281
pubmed: 28319093
Cancer Cell. 2016 Apr 11;29(4):440-451
pubmed: 27070699
Nat Commun. 2015 Apr 20;6:6921
pubmed: 25891015
Blood. 2017 Jul 13;130(2):126-136
pubmed: 28572287
Cell Stem Cell. 2016 Sep 1;19(3):341-54
pubmed: 27476965
Nat Commun. 2013;4:2218
pubmed: 23887712
Blood. 2016 Nov 17;128(20):2381-2387
pubmed: 27707735
Nature. 2018 Apr;556(7702):457-462
pubmed: 29643510
Cancer Cell. 2014 Dec 8;26(6):813-825
pubmed: 25490447
N Engl J Med. 2015 Jul 2;373(1):35-47
pubmed: 26132940

Auteurs

Allan Beke (A)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France.

Lucie Laplane (L)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
CNRS UMR8590, IHPST, Université Paris 1 Panthéon-Sorbonne, Paris, France.

Julie Riviere (J)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.

Qin Yang (Q)

Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA.

Miguel Torres-Martin (M)

Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA.

Thibault Dayris (T)

CNRS 3655 & INSERM US23, AMMICa, Gustave Roussy Cancer Center, Villejuif, France.

Philippe Rameau (P)

CNRS 3655 & INSERM US23, AMMICa, Gustave Roussy Cancer Center, Villejuif, France.

Veronique Saada (V)

Department of Biopathology, Gustave Roussy Cancer Center, Villejuif, France.

Chrystèle Bilhou-Nabera (C)

Service d'Hématologie Biologique, Hôpital Saint-Antoine, Paris, France.

Ana Hurtado (A)

Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.

Larissa Lordier (L)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
CNRS 3655 & INSERM US23, AMMICa, Gustave Roussy Cancer Center, Villejuif, France.

William Vainchenker (W)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.

Maria E Figueroa (ME)

Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA.
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Nathalie Droin (N)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France.

Eric Solary (E)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France eric.solary@gustaveroussy.fr.
Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH